Navigation Links
Varian, Inc. Announces First Quarter 2009 Preliminary Results
Date:1/16/2009

PALO ALTO, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced preliminary results for the first quarter of its fiscal year 2009, which ended January 2, 2009.

First quarter sales should be between $205 million and $210 million. Non- GAAP (adjusted) diluted earnings per share should be between $0.50 and $0.54 including share-based compensation expense of approximately $0.05. On a GAAP basis, diluted earnings per share should be between $0.41 and $0.45. Adjusted operating margins should be between 11.2% and 11.4% in the quarter, while GAAP operating margins should be between 9.4% and 9.6%. Operating cash flow should be between $15 million and $20 million for the quarter.

For a complete reconciliation of non-GAAP (adjusted) financial information used in this press release to the most directly comparable GAAP financial information, please refer to the attached Reconciliations of GAAP to Adjusted Results, Preliminary.

Sales were below expectations in the first quarter primarily due to lower revenues from research products (in particular NMR and imaging systems). Despite order weakness late in the quarter, in particular for certain vacuum and analytical products, total company orders exceeded sales for the quarter. Adjusted operating margins held up well, even on lower revenues, due to the positive impact of efficiency improvements implemented in recent years and favorable foreign currency movements. In addition, operating cash flow was solid during the quarter.

"With respect to our research products sales, we have said many times that the timing of revenues on these products is impacted by factors such as laboratory readiness and access to customer sites, duration of installations and availability of key components and installation personnel," said Garry W. Rogerson, President and Chief Executive Officer. "Although we entered the first quart
'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Varian, Inc. Announces Cost Reduction Plan
2. Varian, Inc. Announces Online Experience
3. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
4. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
5. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
6. Varian, Inc. Board of Directors Makes Officer Changes
7. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
8. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
9. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
10. Varian, Inc. Reports Third Quarter 2008 Results
11. James T. Glover Appointed to Board of Directors of Varian, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , , SAN DIEGO, Nov. 24, 2009 /PRNews...sdaq: ARNA ) announced today that the company i...nnual Health Care Conference on December 1, 2009 a... at the New York Palace Hotel in New York City. Ja...icer, is scheduled to provide an overview of the c...
(Date:11/24/2009)... , , BOZEN, Italy, November 24 /PR...it has formed a new Canadian joint venture with a ...Toronto-based company will operate under the,name ...all, and support,Health Robotics, i.v. Room of the...product offerings i.v.STATION(TM), i.v.SOFT(TM), a...
(Date:11/24/2009)... , Chemical Abstracts Ser...ion, reports that China,s patent office is now the...ications in chemistry. China trailed Japan,s paten...tion (WIPO), and the United States Patent and Trad...assed the USPTO in 2005, WIPO in 2006, and exceede...
(Date:11/23/2009)... , SALT LAKE CITY, Nov. 23, 2009 In a provocati...s that rising carbon dioxide emissions the major ...ss the world,s economy collapses or society builds...h day. , "It looks unlikely that there will be ...observed acceleration in carbon dioxide emission r...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
... Complimentary Continuing Education Virtual Lectur...ORHEES, N.J., Jan. 20 Current education about Cl...or several reasons. The epidemiology of CDI is cha...more severe disease. In addition, the epidemic st... of states across the United States and worldwide....
... LUDWIGSHAFEN, Germany and ST. LOUIS, Jan. 20 ...nounced a new joint-licensing,agreement to acceler...mba-,based weed control chemistry products. Both p...vative formulations for dicamba for use with herbi...of the agreement were not,disclosed. , Researc...
... Sentrx, a New Jersey dru...company grew the number of pharmacovigilance outso...es for the year increased 25% over 2007. The dome... clinical trial and post-marketing safety, managed...tigation strategies. The company maintained its s...
Other Biology Technology:Clostridium difficile Infection: Current Challenges and Controversies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 2BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 3BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies 4Sentrx Exits 2008 with Strong Growth 2Sentrx Exits 2008 with Strong Growth 3
(Date:11/24/2009)...te (LRI) today named 12 new grant recipients for 2...innovative work across a broad spectrum of lupus r...ovelty, and potential to drive scientific discover...ex disease of systemic lupus. , The 2009 grants ...cross the nation and include interdisciplinary and...
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
(Date:11/24/2009)... in Spanish . , The presence of increased b...ry substances in the blood, hinders the loss and m...project of the University of Navarra conducted by ...l of Pharmacy. , The project, entitled "A nutrig...ontrol of body weight and inflammation," examines ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2Experts Urge School Screening of Athletes Hearts 61372 1Experts Urge School Screening of Athletes Hearts 61372 2American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 1American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 2American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 3American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 4American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 5American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 6American Heart Association Late Breaking Clinical Trial Report 3A New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint but Di 6268 7While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 1While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 2
..., Robert Seyfarth, a noted expert on monkey commu...olution of a Social Mind" from 5-6:30 p.m., Tuesda... of Delaware. , The lecture will kick off the Uni...which is sponsored by the Center for International...support from colleges and departments across campu...
..., Representatives from four international agencie...icology Program (NTP), today signed a memorandum o...als required for consumer product safety testing w... Canada, Japan and the European Union will yield g...alternative toxicity testing methods that should s...
..., BOSTON (April 27, 2009) In an in vitro study, l...Medicine, researchers discovered how a protein cal... an enzyme complex that alters the structure of ch... is a compacted mass of DNA and protein that make ...he enzyme complex is of interest in the study of c...
Other Biology News:Beyond 'ooh-ooh, aah-aah'-- expert on monkey communication kicks off Darwin series, May 5 2Countries unite to reduce animal use in product toxicity testing worldwide 2Countries unite to reduce animal use in product toxicity testing worldwide 3SUMO protein guides chromatin remodeler to suppress genes 2
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: